Delivery Order SPE2DB22D2206-SPE2DB26FDS13
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Benlysta 200 mg/ml syringes valued at $3,076.40. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-competitive set-aside. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The contract is set to be completed by October 14, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Benlysta 200 mg/mL syringes valued at $6,152.80, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $6,152.80 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Benlysta 200 mg/ml syringes. This firm fixed-price delivery order will be completed by September 18, 2025, and represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Benlysta 200 mg/ml syringes with a ceiling value of $6,152.80 under firm fixed price terms. This non-set-aside contract is scheduled for completion by May 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, is fulfilling this order...
- The Defense Logistics Agency awarded a $3,076.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/ml syringes, with an ultimate completion date of August 8, 2025. The contract, issued on July 18, 2025, carries no set-aside designation and represents a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Benlysta 200 mg/ml syringes, with a ceiling value of $6,152.80 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with a completion date of September 10, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 9, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. This $6,165.34 firm fixed price delivery order is scheduled for completion by September 3, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,152.80 to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Benlysta 200 mg/ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting the competitive nature of the procurement. This delivery order is issued under...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDS13Delivery Order
The Defense Logistics Agency awarded a $6,152.80 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Benlysta 200 mg/ml syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of November 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive $999.999 billion prime indefinite delivery vehicle with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026. This strategic vehicle enables AmerisourceBergen to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and medical devices. The Benlysta order exemplifies the company's role as a critical pharmaceutical distributor for federal medical procurement, serving the Defense Health Agency and other government healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 10/20/25 |